Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 592 | 7,109 | 3,813 | 8,182 | 1,243 |
| Other current assets | 1,078 | 125 | 86 | 187 | 87 |
| TOTAL | $1,670 | $7,234 | $3,898 | $8,369 | $1,330 |
| Non-Current Assets | |||||
| PPE Net | 1,265 | 1,029 | 816 | 950 | 1,167 |
| Other Non-Current Assets | 1,212 | 0 | 0 | 0 | 0 |
| TOTAL | $2,477 | $1,029 | $816 | $950 | $1,167 |
| Total Assets | $4,146 | $8,263 | $4,714 | $9,319 | $2,496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 36 | 67 | 62 |
| Accounts payable and accrued liabilities | 412 | 491 | 374 | 626 | 645 |
| Accrued Expenses | 474 | 577 | 336 | 141 | 199 |
| TOTAL | $886 | $1,068 | $745 | $834 | $906 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 377 | 0 | 0 | 1,110 | 103 |
| TOTAL | $377 | $N/A | $N/A | $1,110 | $103 |
| Total Liabilities | $1,263 | $1,068 | $745 | $1,944 | $1,009 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96 | 70 | 69 | 47 | 37 |
| Common Shares | 63 | 58 | 185 | 155 | 6,123 |
| Retained earnings | -109,612 | -100,681 | -94,712 | -89,243 | -89,565 |
| TOTAL | $2,883 | $7,195 | $3,969 | $7,375 | $1,487 |
| Total Liabilities And Equity | $4,146 | $8,263 | $4,714 | $9,319 | $2,496 |